Beacon Biosignals secured $86M in Series B funding and expanded its Takeda collaboration, positioning at-home EEG and sleep data as a scalable biomarker layer inside CNS drug development.

Neurological care still depends on infrequent clinic visits, despite symptoms unfolding daily. By turning smartphones into assessment tools, a new approach is emerging to monitor brain health continuously and remotely.

As neuroscience revisits its electrical roots, a new generation of multimodal imaging is bringing timing and structure back together. Combining EEG and fMRI may offer a clearer view of brain network disorders.